Investigation of the Safety, Tolerability and Potential Therapeutic Effects of JNJ-40411813 in Patients With Schizophrenia
Clinical trial NCT01323205 · COMPLETED
Trial details
- NCT number
- NCT01323205
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2012-11-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.